Filter
750
Filtered Results: 750
Text search:
drug
manufacturing
Featured
Recommendations
59
New Publications
189
Language
Document type
No document type
370
Studies & Reports
148
Guidelines
126
Manuals
38
Strategic & Response Plan
37
Fact sheets
12
Situation Updates
8
Training Material
5
Resource Platforms
3
Infographics
2
Brochures
1
Countries / Regions
India
36
Global
33
Kenya
32
Ghana
20
Nigeria
20
Uganda
19
Ethiopia
18
Western and Central Europe
14
South Africa
14
Sierra Leone
13
Bangladesh
13
Nepal
12
Tanzania
12
Zambia
12
Africa
10
Lesotho
9
Malawi
9
Botswana
9
Ukraine
8
Zimbabwe
8
Liberia
8
South–East Asia Region
7
Namibia
7
Myanmar / Burma
7
Rwanda
6
Philippines
6
Latin America and the Carribbean
6
Eastern Europe
5
Indonesia
5
Eswatini/ Swaziland
4
Tajikistan
3
Thailand
3
Albania
3
Haiti
3
Cambodia
3
West and Central Africa
3
East and Southern Africa
3
Russia
3
Cameroon
2
Laos
2
Senegal
2
Mozambique
2
Asia
2
Germany
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Moldova
2
Sudan
2
Pakistan
2
Serbia
1
Australia
1
Benin
1
China
1
Syria
1
Burkina Faso
1
Uzbekistan
1
Mongolia
1
Guinea
1
USA
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Turkmenistan
1
Maldives
1
Mauritius
1
Vietnam
1
Brazil
1
Sri Lanka
1
South Sudan
1
Iraq
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
305
Clinical Guidelines
62
Public Health
30
Pharmacy & Technologies
30
Key Resources
20
Women & Child Health
13
Capacity Building
5
Toolboxes
Pharmacy
86
AMR
85
COVID-19
54
HIV
48
TB
39
Mental Health
34
NTDs
21
Planetary Health
17
Rapid Response
14
Ebola & Marburg
14
NCDs
14
Health Financing Toolbox
12
Global Health Education
12
Specific Hazards
6
Caregiver
6
Conflict
5
Cholera
4
Natural Hazards
3
Malaria
3
Polio
2
Refugee
1
Disability
1
Zika
1
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
Conducted November 2011 to February 2012: Summary Report
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle...
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
For the Fiscal Year 2015-2016, the Health Sector continued to implement actions meant to improve the availability, and access to quality healthcare. The following report highlights achievements registered by the health sector for the fiscal 2015-2016 in different health programs, as well as in the a...
Therapeutics Information and Pharmacovigilance Centre | TIPC
Full eHandbook under: http://www.msh.org/resources/health-systems-in-action-an-ehandbook-for-leaders-and-managers
Effective supply management has the potential to make a powerful contribution to the reliable availability of essential medicines, which are a crucial part of the delivery of highqualit...
These guidelines aim to guide all health care providers in Myanmar, accommodating the situation of different settings in the context of progressive decentralization of HIV services. Notable changes from the previous edition include:
• diagnosis of HIV
• update on the initiation of ART<...
• diagnosis of HIV
• update on the initiation of ART<...
2014-2020, Draft March 2014
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Данное руководство содержит детальное описание стратегии диагностики и ведения пациентов с лекарственно-устойчивыми формами ТБ, прежде всего с туберкулезом с мн...
